Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jane J Kim

Showing results (41-50 of 196) with videos related to

Pageof 20
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 23, 2017
Age of Acquiring Causal Human Papillomavirus (HPV) Infections: Leveraging Simulation Models to Explore the Natural History of HPV-induced Cervical CancerEmily A Burger, Jane J Kim, Stephen Sy, et al.
BMJ Global Health|November 2, 2021
Projections of human papillomavirus (HPV) vaccination impact in Ethiopia, India, Nigeria and Pakistan: a comparative modelling studyAllison Portnoy, Kaja Abbas, Steven Sweet, et al.
Journal of the National Cancer Institute|October 19, 2016
Optimal Cervical Cancer Screening in Women Vaccinated Against Human PapillomavirusJane J Kim, Emily A Burger, Stephen Sy, et al.
American Journal of Obstetrics and Gynecology|September 21, 2021
Cost-effectiveness analysis of the 2019 American Society for Colposcopy and Cervical Pathology Risk-Based Management Consensus Guidelines for the management of abnormal cervical cancer screening tests and cancer precursorsVidit N Munshi, Rebecca B Perkins, Stephen Sy, et al.
MDM Policy & Practice|January 13, 2022
Impact of Delaying Effective and Cost-Effective Policy Decisions: An Example From Cervical Cancer Prevention in NorwayAllison Portnoy, Mari Nygård, Lill Trogstad, et al.
International Journal of Cancer|May 7, 2015
Cervical cancer screening in low-resource settings: A cost-effectiveness framework for valuing tradeoffs between test performance and program coverageNicole G Campos, Philip E Castle, Thomas C Wright, et al.
Plos Medicine|November 16, 2006
Packaging health services when resources are limited: the example of a cervical cancer screening visitJane J Kim, Joshua A Salomon, Milton C Weinstein, et al.
Vaccine|December 17, 2013
Model-based impact and cost-effectiveness of cervical cancer prevention in sub-Saharan AfricaJane J Kim, Nicole G Campos, Meredith O'Shea, et al.
Cancer Medicine|July 15, 2017
Evidence-based policy choices for efficient and equitable cervical cancer screening programs in low-resource settingsNicole G Campos, Vivien Tsu, Jose Jeronimo, et al.
BMC Cancer|November 28, 2017
Estimating the value of point-of-care HPV testing in three low- and middle-income countries: a modeling studyNicole G Campos, Vivien Tsu, Jose Jeronimo, et al.
Pageof 20

Showing results (41-50 of 196) with videos related to

Sort By:
Pageof 20
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 23, 2017
Age of Acquiring Causal Human Papillomavirus (HPV) Infections: Leveraging Simulation Models to Explore the Natural History of HPV-induced Cervical CancerEmily A Burger, Jane J Kim, Stephen Sy, et al.
BMJ Global Health|November 2, 2021
Projections of human papillomavirus (HPV) vaccination impact in Ethiopia, India, Nigeria and Pakistan: a comparative modelling studyAllison Portnoy, Kaja Abbas, Steven Sweet, et al.
Journal of the National Cancer Institute|October 19, 2016
Optimal Cervical Cancer Screening in Women Vaccinated Against Human PapillomavirusJane J Kim, Emily A Burger, Stephen Sy, et al.
American Journal of Obstetrics and Gynecology|September 21, 2021
Cost-effectiveness analysis of the 2019 American Society for Colposcopy and Cervical Pathology Risk-Based Management Consensus Guidelines for the management of abnormal cervical cancer screening tests and cancer precursorsVidit N Munshi, Rebecca B Perkins, Stephen Sy, et al.
MDM Policy & Practice|January 13, 2022
Impact of Delaying Effective and Cost-Effective Policy Decisions: An Example From Cervical Cancer Prevention in NorwayAllison Portnoy, Mari Nygård, Lill Trogstad, et al.
International Journal of Cancer|May 7, 2015
Cervical cancer screening in low-resource settings: A cost-effectiveness framework for valuing tradeoffs between test performance and program coverageNicole G Campos, Philip E Castle, Thomas C Wright, et al.
Plos Medicine|November 16, 2006
Packaging health services when resources are limited: the example of a cervical cancer screening visitJane J Kim, Joshua A Salomon, Milton C Weinstein, et al.
Vaccine|December 17, 2013
Model-based impact and cost-effectiveness of cervical cancer prevention in sub-Saharan AfricaJane J Kim, Nicole G Campos, Meredith O'Shea, et al.
Cancer Medicine|July 15, 2017
Evidence-based policy choices for efficient and equitable cervical cancer screening programs in low-resource settingsNicole G Campos, Vivien Tsu, Jose Jeronimo, et al.
BMC Cancer|November 28, 2017
Estimating the value of point-of-care HPV testing in three low- and middle-income countries: a modeling studyNicole G Campos, Vivien Tsu, Jose Jeronimo, et al.
Pageof 20